Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners. Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint. Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food & beverage, cosmetic, therapeutic, and agricultural industries. With Provectus Algae our partners enjoy… 1). Rapid Speed to Market Through End-to-End Supply Solutions 2). Environmentally Sustainable Biomanufacturing 3). Novel Natural and Biosynthetic Products from Algae Reach out today to start making your molecules using light and CO2, all while helping to build a more sustainable bioeconomy.
Location: Australia
Employees: 11-50
Total raised: $35.35M
Founded date: 2018
Investors 2
| Date | Name | Website |
| 06.06.2024 | Unreasonab... | unreasonab... |
| - | Maropost V... | maropost.v... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 25.07.2025 | Series A | $12.6M | At One Ven... |
| 14.12.2021 | Series A | $11.4M | - |
| 13.12.2021 | Seed | $8.1M | - |
| 22.10.2020 | - | $3.25M | - |
Mentions in press and media 21
| Date | Title | Description |
| 25.07.2025 | Provectus Algae: $12.6 Million Series A Raised For Carbon-Negative Solutions | Provectus Algae has raised $10.1 million in Series A financing and an additional $2.5 million in grant funding from the Australian government. The investment round was led by At One Ventures, with contributions from Methane Mitigation, Mort... |
| 24.07.2025 | Provectus Algae Secures $12.6M: Revolutionizing Livestock Methane Reduction with Algae Technology | Provectus Algae secured $12.6M Series A funding, including a significant Australian government grant. At One Ventures led this crucial investment round. This capital accelerates the production scale of Surf'N'Turf, an innovative algae-based... |
| 22.07.2025 | Provectus Algae Raises $12.6M in Series A Funding | Provectus Algae, a Noosaville, Australia-based biomanufacturing technologies company, raised $12.6M in Series a funding. The round was led by At One Ventures and included Methane Mitigation, Mort & Co, and existing shareholders, such as... |
| 22.07.2025 | Provectus Algae Raises $12.6M in Series A Led by At One Ventures and Grant Funding | NOOSAVILLE, Australia–(BUSINESS WIRE)–July 22, 2025– Provectus Algae (Provectus) announced today that it has raised US$10.1M in Series A financing and an additional US$2.5M in grant funding from the Australian government. The round was led ... |
| 02.11.2023 | Provectus Algae Enters Into Livestock Methane Reduction Space Commissioning First Demonstration Biomanufacturing Plant | NOOSA, Australia–(BUSINESS WIRE)–November 2, 2023– Provectus Algae (Provectus) has announced its entry into livestock methane reduction with its first 30,000 L demonstration plant commissioned in October to scale up Asparagopsis feed additi... |
| 31.05.2023 | Algae’s second bloom? ‘Resiliency and productivity are key,’ say second generation startups | Between 2005-2012, venture capitalists poured millions of dollars into startups attempting to make fuel from microalgae, getting their fingers badly burned in the process. But could algae be gearing up for a second bloom? “Having gone throu... |
| 23.03.2023 | The Week in AgriFoodTech: Oatly raises $425m, Cocoon Bioscience bags $16 million to turn moths into bioreactors | This week, loss-making Oatly raised $425m as it “moves towards reaching financial self-sufficiency,” Cocoon Bioscience bagged $16 million to turn moths into bioreactors, and Klimato secured €4.2 million ($4.5 million) to expand its platform... |
| 21.03.2023 | Former Estée Lauder Executive Joins Provectus Algae as Cosmetics Advisor Signalling Industry Expansion | NOOSAVILLE, Australia–(BUSINESS WIRE)–March 21, 2023– Provectus Algae (Provectus) has announced that Steven F. Schnittger has joined the company as a cosmetics industry advisor. Schnittger is the former Vice-President of Global Fermentation... |
| 17.03.2023 | Provectus Algae to expand ‘carbon negative’ biomanufacturing ingredients platform with new funding | Sugar-eating organisms such as yeast and bacteria dominate industrial fermentation today. But organisms that eat more sustainable feedstocks will be the “predominant biomanufacturing platforms of tomorrow” if we are serious about decarboniz... |
| 03.03.2023 | Provectus Algae Receives Strategic Investment from CJ Bio | Provectus Algae, a Noosaville, Australia-based biotech company focusing on algae proprieties, received a strategic investment from CJ BIO, a division of South Korea-based food & bio company CJ CheilJedang. The amount of the deal was not... |
Show more